Investor Relations

Recent News
Mar 23, 2021

Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer, granted a stock option to a new employee as approved...

Mar 11, 2021

– MOMENTUM Phase 3 Trial on Track to Complete Enrollment in mid-2021 with Top-line Data Anticipated in H1 2022 – – Data Presented Throughout the Year Included Long-Term Overall Survival,...

Mar 3, 2021

—HC Wainwright Life Sciences Conference beginning at 7:00 am ET on March 9th— —Roth Conference at 10:00 am ET on March 15th— —Oppenheimer Healthcare Conference at 1:50 pm ET on March 17th—

View all news releases

Events and Webcasts
Wednesday, March 17, 2021
1:50pm - 2:20pm EDT

Presenter: Stephen G. Dilly, President & CEO

View all events and webcasts

Investor Enquiries

Dede Sheel
Vice President, Investor Relations
investors@sierraoncology.com

Sign up for investor alerts